
Samantha L. Shterengarts
Examiner (ID: 8624, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623, 4131 |
| Total Applications | 2403 |
| Issued Applications | 1806 |
| Pending Applications | 134 |
| Abandoned Applications | 481 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15496225
[patent_doc_number] => 20200048301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => EPOXY-(METH)ACRYLATE MONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/538989
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538989 | Epoxy-(meth)acrylate monomers and polymers and methods of making and using the same | Aug 12, 2019 | Issued |
Array
(
[id] => 16869955
[patent_doc_number] => 20210163422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/263243
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263243 | Reagents based on a tertiary amine backbone to introduce chemical functionality in nucleic acids and sequence-controlled polymers | Aug 8, 2019 | Issued |
Array
(
[id] => 15454339
[patent_doc_number] => 20200039994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => HETEROARYL AMIDE COMPOUNDS AS STING ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/528062
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 3612
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/528062 | Heteroaryl amide compounds as sting activators | Jul 30, 2019 | Issued |
Array
(
[id] => 15435149
[patent_doc_number] => 20200031758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => CRYSTALLINE EPINEPHRINE MALONATE SALT
[patent_app_type] => utility
[patent_app_number] => 16/526286
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526286 | Crystalline epinephrine malonate salt | Jul 29, 2019 | Issued |
Array
(
[id] => 17905455
[patent_doc_number] => 11459298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Class of dicationic compounds as well as the preparative method and the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/044520
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4283
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044520 | Class of dicationic compounds as well as the preparative method and the use thereof | Jul 23, 2019 | Issued |
Array
(
[id] => 15618789
[patent_doc_number] => 20200079799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Novel Chiral Alfa-Amino Tertiary Boronic Esters
[patent_app_type] => utility
[patent_app_number] => 16/519037
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519037
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519037 | Chiral a-amino tertiary boronic esters | Jul 22, 2019 | Issued |
Array
(
[id] => 17081961
[patent_doc_number] => 20210276967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => INHIBITORS OF HEPATITIS B VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/261223
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261223 | INHIBITORS OF HEPATITIS B VIRUS | Jul 18, 2019 | Abandoned |
Array
(
[id] => 17526784
[patent_doc_number] => 11299455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Process for diastereoselective synthesis of vicinal diamines
[patent_app_type] => utility
[patent_app_number] => 17/256962
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3078
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256962 | Process for diastereoselective synthesis of vicinal diamines | Jul 10, 2019 | Issued |
Array
(
[id] => 16540922
[patent_doc_number] => 20200407335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SURFACTANTS FROM LONG-CHAIN CARBON-CONTAINING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/757447
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757447 | Surfactants from long-chain carbon-containing molecules | Jul 9, 2019 | Issued |
Array
(
[id] => 18158918
[patent_doc_number] => 20230025510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/257238
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257238 | BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15038391
[patent_doc_number] => 20190330200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS KALLIKREIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/460630
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460630 | N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors | Jul 1, 2019 | Issued |
Array
(
[id] => 16970474
[patent_doc_number] => 11066435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Green methods for preparing highly CO2 selective and H2S tolerant metal organic frameworks
[patent_app_type] => utility
[patent_app_number] => 16/458833
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 4523
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16458833
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/458833 | Green methods for preparing highly CO2 selective and H2S tolerant metal organic frameworks | Jun 30, 2019 | Issued |
Array
(
[id] => 17875496
[patent_doc_number] => 11447497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
[patent_app_type] => utility
[patent_app_number] => 17/256142
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38281
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2078
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256142 | (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases | Jun 27, 2019 | Issued |
Array
(
[id] => 17036604
[patent_doc_number] => 20210253562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/250146
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250146 | ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS | Jun 27, 2019 | Abandoned |
Array
(
[id] => 18384472
[patent_doc_number] => 11655241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Heterocyclic compound and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/973320
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20364
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973320 | Heterocyclic compound and use thereof | Jun 26, 2019 | Issued |
Array
(
[id] => 15267377
[patent_doc_number] => 20190382422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/451883
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451883
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451883 | SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF | Jun 24, 2019 | Abandoned |
Array
(
[id] => 16839350
[patent_doc_number] => 20210147362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PROCESS FOR THE PREPARATION OF QUINMERAC
[patent_app_type] => utility
[patent_app_number] => 17/254952
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254952 | Process for the preparation of Quinmerac | Jun 23, 2019 | Issued |
Array
(
[id] => 17094608
[patent_doc_number] => 20210282399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => FUNGICIDAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/252661
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252661 | FUNGICIDAL COMPOSITION | Jun 18, 2019 | Abandoned |
Array
(
[id] => 14929759
[patent_doc_number] => 20190300517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/438061
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 654
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438061 | N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors | Jun 10, 2019 | Issued |
Array
(
[id] => 15708563
[patent_doc_number] => 20200101047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/432445
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16432445
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/432445 | Inhibitors of integrated stress response pathway | Jun 4, 2019 | Issued |